Literature DB >> 2529865

Pilot trial to prevent type I diabetes: progression to overt IDDM despite oral nicotinamide.

R D Herskowitz1, R A Jackson, J S Soeldner, G S Eisenbarth.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2529865     DOI: 10.1016/s0896-8411(89)80011-3

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


× No keyword cloud information.
  8 in total

Review 1.  Immunotherapy of immune-mediated diabetes. Present and future.

Authors:  N Maclaren
Journal:  Clin Rev Allergy Immunol       Date:  2000-12       Impact factor: 8.667

Review 2.  Lessons from type 1 diabetes for understanding natural history and prevention of autoimmune disease.

Authors:  Kimber Simmons; Aaron W Michels
Journal:  Rheum Dis Clin North Am       Date:  2014-09-02       Impact factor: 2.670

Review 3.  Pharmacological approaches to the prevention of autoimmune diabetes.

Authors:  W E Winter; D V House; D Schatz
Journal:  Drugs       Date:  1997-06       Impact factor: 9.546

Review 4.  Strategies for preventing type I diabetes mellitus.

Authors:  C F Verge; G S Eisenbarth
Journal:  West J Med       Date:  1996-03

Review 5.  Immune Intervention and Preservation of Pancreatic Beta Cell Function in Type 1 Diabetes.

Authors:  Kimber M Simmons; Peter A Gottlieb; Aaron W Michels
Journal:  Curr Diab Rep       Date:  2016-10       Impact factor: 4.810

6.  Oxygen radicals generated by the enzyme xanthine oxidase lyse rat pancreatic islet cells in vitro.

Authors:  V Burkart; T Koike; H H Brenner; H Kolb
Journal:  Diabetologia       Date:  1992-11       Impact factor: 10.122

7.  Immunotherapy trials for type 1 diabetes: the contribution of George Eisenbarth.

Authors:  Jay S Skyler; Alberto Pugliese
Journal:  Diabetes Technol Ther       Date:  2013-06       Impact factor: 6.118

8.  Prevention or delay of type 1 (insulin-dependent) diabetes mellitus in children using nicotinamide.

Authors:  R B Elliott; H P Chase
Journal:  Diabetologia       Date:  1991-05       Impact factor: 10.122

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.